438 results
UPLOAD
SEEL
Seelos Therapeutics Inc
15 Jul 05
Letter from SEC
12:00am
persons who are responsible for the accuracy and
adequacy of the disclosure in the filing to be certain that the
filing include all information … the company
and
its management are in possession of all facts relating to a
company`s
disclosure, they are responsible for the accuracy and adequacy
10-K405
2001 FY
EX-10.9
SEEL
Seelos Therapeutics Inc
29 Mar 02
Annual report (delinquent filer disclosure)
12:00am
- --------- limiting the generality of the foregoing, Lessee
would be responsible for all expenses, maintenance … : Lessee would bear all risk of loss or damage to the
- --------- Equipment. Lessee would be responsible to keep
10-K405
2001 FY
EX-10.8
SEEL
Seelos Therapeutics Inc
29 Mar 02
Annual report (delinquent filer disclosure)
12:00am
by
this proposal.
NET LEASE:
- --- -----
The proposed lease would be a net lease. Without limiting the generality of the
foregoing, Lessee would be responsible … bear all risk of loss or damage to the Equipment. Lessee would be
responsible to keep the Equipment insured with companies acceptable to Lessor
8-K
EX-10.10
g06fv
23 Feb 98
Current report
12:00am
8-K
EX-10.1
dprogwuxn h3sg23h5
20 Oct 14
Apricus Expands Development Pipeline
12:00am
8-K
EX-99.1
c44 awt9h
16 Jan 19
Entry into a Material Definitive Agreement
12:00am
UPLOAD
iv13 mmn580
21 Dec 23
Letter from SEC
12:00am
UPLOAD
2acww qy2ix10le3zq
18 Dec 20
Letter from SEC
12:00am
8-K
EX-10.1
x66dpu2
24 Nov 21
Seelos Therapeutics Announces Acquisition of an Exclusive License of iX Biopharma’s Proprietary Wafer-Based Delivery Platform for Sublingual Ketamine
8:20am
S-4/A
EX-10.33
quukynev8eu9de
24 Oct 18
Registration of securities issued in business combination transactions (amended)
4:56pm
8-K
EX-99.1
puyd0wndg6palr 7n
4 Jan 19
Entry into a Material Definitive Agreement
5:22pm